Thomas J. Herzfeld Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,882	Closed	-$33K	–	315
2018 Q4	$33K	Sell	11,882 -747	-6%	-$2.45K	0.01%	193
2018 Q3	$52K	Hold	12,629	–	–	0.02%	161
2018 Q2	$66K	Buy	+12,629	New	+$76.9K	0.02%	167
2014 Q2	–	Sell	-3,000	Closed	-$12K	–	313
2014 Q1	$12K	Hold	3,000	–	–	0.01%	256
2013 Q4	$9K	Hold	3,000	–	–	0.01%	286
2013 Q3	$8K	Hold	3,000	–	–	0.01%	267
2013 Q2	$6K	Buy	+3,000	New	+$6.62K	﹤0.01%	275

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thomas J. Herzfeld Advisors's ENZ Position: Q1 2019 in Review

Thomas J. Herzfeld Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q1 2019, closing a stake of 11,882 shares — an estimated $33K sold.

Thomas J. Herzfeld Advisors first reported a position in ENZ in Q2 2013 and held it in 7 quarters. The position peaked at $66K in Q2 2018. 85 funds tracked by Wall St. Rank hold ENZ as of Q1 2019.

Thomas J. Herzfeld Advisors reported no remaining Enzo Biochem, Inc. position as of Q1 2019 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 11,882 Enzo Biochem, Inc. shares in Q1 2019, an estimated $33K.
Thomas J. Herzfeld Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 7 quarters.
Thomas J. Herzfeld Advisors's Enzo Biochem, Inc. position peaked at $66K in Q2 2018.
85 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2019.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q1 2019, filed 14 May 2019.